Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores

Design of clinical trials requires careful decision-making across several dimensions, including endpoints, eligibility criteria, and subgroup enrichment. Clinical trial simulation can be an informative tool in trial design, providing empirical evidence by which to evaluate and compare the results of...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Weinstein, SM, Coates, LC, Helliwell, PS, Ogdie, A, Stephens-Shields, AJ
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	SAGE Publications 2021

Eitemau Tebyg

Psoriatic arthritis: prospects for the future
gan: Hackett, S, et al.
Cyhoeddwyd: (2022)

Measuring outcomes in psoriatic arthritis
gan: Ogdie, A, et al.
Cyhoeddwyd: (2020)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
gan: P.S. Helliwell
Cyhoeddwyd: (2011-09-01)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
gan: Helliwell, PS, et al.
Cyhoeddwyd: (2022)

What should be the primary target of "treat to target" in psoriatic arthritis?
gan: Coates, LC, et al.
Cyhoeddwyd: (2018)

Psoriatic arthritis: prospects for the future
gan: Simon Hackett, et al.
Cyhoeddwyd: (2022-03-01)

Psoriatic arthritis
gan: FitzGerald, O, et al.
Cyhoeddwyd: (2021)

Comparing the visual analogue scale and the numerical rating scale in patient-reported outcomes in psoriatic arthritis
gan: Ye, W, et al.
Cyhoeddwyd: (2021)

Inhibition of interleukin-17 in patients with oligoarticular psoriatic arthritis
gan: Ogdie, A, et al.
Cyhoeddwyd: (2023)

The role of ultrasound in psoriatic arthritis — do we need a score?
gan: D'Agostino, MA, et al.
Cyhoeddwyd: (2019)

Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis
gan: Coates, LC, et al.
Cyhoeddwyd: (2022)

Measuring physical function in psoriatic arthritis: comparing the Multi-Dimensional Health Assessment Questionnaire to the Health Assessment Questionnaire Disability Index
gan: Ye, W, et al.
Cyhoeddwyd: (2021)

Current concepts and unmet needs in psoriatic arthritis
gan: Mahmood, F, et al.
Cyhoeddwyd: (2017)

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
gan: Coates, L, et al.
Cyhoeddwyd: (2019)

Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
gan: Helliwell, PS, et al.
Cyhoeddwyd: (2021)

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
gan: Coates, L, et al.
Cyhoeddwyd: (2020)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
gan: Coates, L, et al.
Cyhoeddwyd: (2016)

Outcome measures in psoriatic arthritis: where next?
gan: Hackett, S, et al.
Cyhoeddwyd: (2022)

Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis
gan: Laure Gossec, et al.
Cyhoeddwyd: (2024-02-01)

Assessing disease activity in psoriatic arthritis: a literature review
gan: Tucker, L, et al.
Cyhoeddwyd: (2018)

The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study
gan: Helliwell, PS, et al.
Cyhoeddwyd: (2023)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
gan: Gladman, DD, et al.
Cyhoeddwyd: (2022)

Classification and outcome measures for psoriatic arthritis
gan: Leung, Y, et al.
Cyhoeddwyd: (2018)

Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
gan: Vivekanantham, A, et al.
Cyhoeddwyd: (2024)

Sex-specific differences in patients with psoriatic arthritis: a systematic review
gan: Coates, LC, et al.
Cyhoeddwyd: (2022)

Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review
gan: Leung, Y-Y, et al.
Cyhoeddwyd: (2020)

Outcomes of the 2019 GRAPPA workshop on continuous composite indices for the assessment of psoriatic arthritis and membership: Recommended next steps
gan: Tillett, W, et al.
Cyhoeddwyd: (2020)

How should we define disease and outcomes in axial psoriatic arthritis?
gan: Coates, LC
Cyhoeddwyd: (2021)

Identification of psoriatic arthritis in patients with psoriasis
gan: Coates, LC, et al.
Cyhoeddwyd: (2023)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
gan: Soriano, ER, et al.
Cyhoeddwyd: (2023)

The State of the Art - Psoriatic Arthritis outcome assessment in clinical trials and daily practice
gan: Day, J, et al.
Cyhoeddwyd: (2022)

New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation
gan: Coates, L, et al.
Cyhoeddwyd: (2016)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
gan: Atul Deodhar, et al.
Cyhoeddwyd: (2022-07-01)

Psoriatic Arthritis: A Review
gan: Farrouq Mahmood, et al.
Cyhoeddwyd: (2016-07-01)

Obesity and Psoriatic Arthritis: A Narrative Review
gan: Anand Kumthekar, et al.
Cyhoeddwyd: (2020-06-01)

Classification and Outcome Measures for Psoriatic Arthritis
gan: Ying Ying Leung, et al.
Cyhoeddwyd: (2018-09-01)

Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
gan: Alexis Ogdie, et al.
Cyhoeddwyd: (2023-05-01)

Psoriatic arthritis in developing and resource-poor countries
gan: Maharaj, AB, et al.
Cyhoeddwyd: (2020)

Methotrexate in psoriasis and psoriatic arthritis
gan: Coates, L, et al.
Cyhoeddwyd: (2020)

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies
gan: Tillett, W, et al.
Cyhoeddwyd: (2017)